Filing Flows › Companies › Lucid Diagnostics › Report card
Lucid Diagnostics earnings report card
Every report on file against what analysts and the company itself expected, and what the stock did
Beat rate0 of 4 reports beat the EPS estimate
Lucid Diagnostics (LUCD) beat the analysts' EPS estimate in 0 of its last 4 reports (0%), by -12.6% on average. Next report: Nov 12, 2026, analysts expect EPS −$0.06.
Report by report
| Quarter | Reported | EPS est. | EPS reported | Surprise | Revenue reported |
|---|---|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | −$0.06 | −$0.06 | -9.1% | $1.5M |
| Q1 2026 | May 14, 2026 | −$0.06 | −$0.07 | -10.5% | $1.3M |
| Q to Dec 2025 | Mar 26, 2026 | −$0.09 | −$0.10 | -15.4% | — |
| Q3 2025 | Nov 12, 2025 | −$0.09 | −$0.10 | -15.4% | $1.2M |
Estimates and reported EPS are the Street's adjusted figures. Revenue reported is from the company's filing. No daily prices are on file for these report days, so the stock's moves are not shown.
Charts
The next report: what to expect → Lucid Diagnostics: every quarter →
Read automatically from SEC filings, earnings releases and public estimates; errors are possible. Not investment advice.